Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs.

Castaño, Adam; Drachman, Brian M; Judge, Daniel; Maurer, Mathew S

Castaño, Adam; Drachman, Brian M; Judge, Daniel; Maurer, Mathew S.

Affiliation

Castaño A; Center for Advanced Cardiac Care, Columbia College of Physicians and Surgeons, New York City, NY, USA, ac3220@cumc.columbia.edu.

Heart Fail Rev ; 20(2): 163-78, 2015 Mar.

Article in En | MEDLINE | ID: mdl-25408161

Subject(s)

Amyloid Neuropathies, Familial/diagnosis; Amyloid Neuropathies, Familial/therapy; Cardiomyopathies/therapy; Heart Failure/therapy; Benzoxazoles/therapeutic use; Biomarkers; Cyclooxygenase Inhibitors/therapeutic use; Defibrillators, Implantable; Diflunisal/therapeutic use; Doxycycline/therapeutic use; Humans; Oligonucleotides, Antisense/therapeutic use; Organ Transplantation; Pacemaker, Artificial; RNA, Small Interfering/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyloid Neuropathies, Familial / Heart Failure / Cardiomyopathies Limits: Humans Language: En Journal: Heart Fail Rev Journal subject: CARDIOLOGIA Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google